Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beatriz Fernandez-Fernandez

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
The Lancet. Diabetes & Endocrinology|June 2, 2015
Humble kidneys predict mighty heart troublesAlberto Ortiz, Beatriz Fernandez-Fernandez
The Lancet. Diabetes & Endocrinology|November 7, 2017
Paricalcitol and albuminuria: tread carefullyBeatriz Fernandez-Fernandez, Alberto Ortiz
Lancet (London, England)|June 5, 2026
Finerenone: kidney protection beyond type 2 diabetesAlberto Ortiz, Beatriz Fernandez-Fernandez
Clinical Journal of the American Society of Nephrology : CJASN|December 2, 2021
Atrasentan: The Difficult Task of Integrating Endothelin A Receptor Antagonists into Current Treatment Paradigm for Diabetic Kidney DiseaseAlberto Ortiz, Beatriz Fernandez-Fernandez
The New England Journal of Medicine|October 11, 2023
Zilebesiran for HypertensionDaria Abasheva, Beatriz Fernandez-Fernandez, Alberto Ortiz
The New England Journal of Medicine|July 2, 2025
Intensive Blood-Pressure Control in Patients with Type 2 DiabetesBeatriz Fernandez-Fernandez, Pantelis Sarafidis, Alberto Ortiz
Annals of Internal Medicine|April 17, 2023
First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor AgonistsSol Carriazo, Alberto Ortiz, Beatriz Fernandez-Fernandez
Clinical Kidney Journal|November 25, 2024
GLP-1 receptor agonists in patients with chronic kidney disease and either overweight or obesityDaria Abasheva, Alberto Ortiz, Beatriz Fernandez-Fernandez
Kidney International|November 1, 2014
Bicarbonate therapy, phosphate binders, and risk for vascular calcificationBeatriz Fernandez-Fernandez, Catalina Martin-Cleary, Alberto Ortiz
Clinical Kidney Journal|February 10, 2018
Women and renal replacement therapy in Europe: lower incidence, equal access to transplantation, longer survival than menRaul Fernandez-Prado, Beatriz Fernandez-Fernandez, Alberto Ortiz
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
The Lancet. Diabetes & Endocrinology|June 2, 2015
Humble kidneys predict mighty heart troublesAlberto Ortiz, Beatriz Fernandez-Fernandez
The Lancet. Diabetes & Endocrinology|November 7, 2017
Paricalcitol and albuminuria: tread carefullyBeatriz Fernandez-Fernandez, Alberto Ortiz
Lancet (London, England)|June 5, 2026
Finerenone: kidney protection beyond type 2 diabetesAlberto Ortiz, Beatriz Fernandez-Fernandez
Clinical Journal of the American Society of Nephrology : CJASN|December 2, 2021
Atrasentan: The Difficult Task of Integrating Endothelin A Receptor Antagonists into Current Treatment Paradigm for Diabetic Kidney DiseaseAlberto Ortiz, Beatriz Fernandez-Fernandez
The New England Journal of Medicine|October 11, 2023
Zilebesiran for HypertensionDaria Abasheva, Beatriz Fernandez-Fernandez, Alberto Ortiz
The New England Journal of Medicine|July 2, 2025
Intensive Blood-Pressure Control in Patients with Type 2 DiabetesBeatriz Fernandez-Fernandez, Pantelis Sarafidis, Alberto Ortiz
Annals of Internal Medicine|April 17, 2023
First-Line Therapy for Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor AgonistsSol Carriazo, Alberto Ortiz, Beatriz Fernandez-Fernandez
Clinical Kidney Journal|November 25, 2024
GLP-1 receptor agonists in patients with chronic kidney disease and either overweight or obesityDaria Abasheva, Alberto Ortiz, Beatriz Fernandez-Fernandez
Kidney International|November 1, 2014
Bicarbonate therapy, phosphate binders, and risk for vascular calcificationBeatriz Fernandez-Fernandez, Catalina Martin-Cleary, Alberto Ortiz
Clinical Kidney Journal|February 10, 2018
Women and renal replacement therapy in Europe: lower incidence, equal access to transplantation, longer survival than menRaul Fernandez-Prado, Beatriz Fernandez-Fernandez, Alberto Ortiz
Pageof 8